MEDIFUN CORPORATION
Taiwan臺中市南屯區精科南路99號4樓之14 products representedNov 25, 2014 – Dec 21, 2018
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Products represented
3
Manufacturers
4
Active products
Dec 2018
Latest registration
Company details
- Address
- 臺中市南屯區精科南路99號4樓之1
- Authorization Code
- 54590159
Regulatory footprint
Search MEDIFUN CORPORATION across other regulatory registries
Recent registrations
Latest 5 products represented by this organization
Most popular products
Products with most registrations
Represented manufacturers
Manufacturers whose products are represented by this organization
Recent represented products
Most recent products (showing top 20)
"Ruikang" safety blood collection needle (sterilization)
Registered: Dec 21, 2018 • Expires: Dec 21, 2028
- Risk Class
- Class 1
- Manufacturer
- NINGBO MEDSUN MEDICAL CO., LTD.
"Ruikang" blood collection needle (sterilized)
Registered: Sep 17, 2018 • Expires: Sep 17, 2028
- Risk Class
- Class 1
- Manufacturer
- NINGBO MEDSUN MEDICAL CO., LTD.
"Ruikang" blood collection needle (sterilization)
Registered: Apr 13, 2015 • Expires: Apr 13, 2025
- Risk Class
- Class 1
- Manufacturer
- TIANJIN HUAHONG TECHNOLOGY CO.,LTD
"Ruikang" blood collection pen (unsterilized)
Registered: Nov 25, 2014 • Expires: Nov 25, 2029
- Risk Class
- Class 1
- Manufacturer
- Ruikang Biomedical Co., Ltd. Precision Factory
About this profile
Explore comprehensive authorized representative profile for MEDIFUN CORPORATION through Pure Global AI's free Taiwan medical device database. This authorized representative handles 4 product registrations across 3 manufacturers and 4 unique product types. Their regulatory history spans from Nov 25, 2014 to Dec 21, 2018.
This page provides detailed insights including 4 recent product registrations, 4 most popular products with "Ruikang" safety blood collection needle (sterilization) having 1 registrations, and 3 represented manufacturers including NINGBO MEDSUN MEDICAL CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.